Agree Realty Corporation logo

Agree Realty Corporation (ADC)

Market Open
15 Dec, 18:17
NYSE NYSE
$
71. 58
-0.17
-0.24%
$
8.11B Market Cap
- P/E Ratio
1.01% Div Yield
231,692 Volume
- Eps
$ 71.75
Previous Close
Day Range
71.51 72.25
Year Range
67.58 79.65
Want to track ADC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 57 days
Is Agree Realty a Millionaire Maker?

Is Agree Realty a Millionaire Maker?

Net lease real estate investment trust (REIT) Agree Realty (ADC 1.39%) has a 4.1% dividend yield. That yield is a little higher than the 3.7% average for the REIT sector, but below the 5.6% you could get from buying industry leading net lease REIT Realty Income.

Fool | 1 year ago
What I Wish I Knew Before Investing In REITs

What I Wish I Knew Before Investing In REITs

I have done well over time, but I could have done even better. I have made many mistakes over the years. I discuss 3 of my biggest regrets as a REIT investor.

Seekingalpha | 1 year ago
ADC Therapeutics: Continues To Make Strides With ZYNLONTA Targeting DLBCL

ADC Therapeutics: Continues To Make Strides With ZYNLONTA Targeting DLBCL

Initial positive results released from the phase 1b study, using ZYNLONTA + COLUMVI for the treatment of patients with 2nd-line relapsed/refractory DLBCL. Additional results from the phase 1b study, using ZYNLONTA + COLUMVI for the treatment of patients with 2nd-line relapsed/refractory DLBCL, to be released in the 1st half of 2025. The seven major Diffuse Large B-cell Lymphoma markets are expected to reach $5.25 billion by 2034.

Seekingalpha | 1 year ago
2 REITs To Buy After The Rally

2 REITs To Buy After The Rally

REITs are up 40% on average over the past year. But some individual REITs are not up at all. I discuss 2 REITs that remain heavily discounted.

Seekingalpha | 1 year ago
3 Durable Dividend Stocks to Buy for a Lifetime of Passive Income

3 Durable Dividend Stocks to Buy for a Lifetime of Passive Income

Some dividends are more durable than others. That's due to a combination of the underlying company's financial strength and the resiliency of its business model.

Fool | 1 year ago
My Single Biggest Regret As A REIT Investor

My Single Biggest Regret As A REIT Investor

I have outperformed REIT sector averages over the long run. But I could have done even better. I discuss my #1 biggest mistake I have made as a REIT investor.

Seekingalpha | 1 year ago
9 Stocks I'm Buying As The Market Reaches A Rare Level Of Speculative Fervor

9 Stocks I'm Buying As The Market Reaches A Rare Level Of Speculative Fervor

The U.S. stock market is highly valued, driven by Big Tech and AI investments, with speculative fervor reminiscent of the late 1990s. Some REITs, like W.P. Carey, face challenges due to poor capital allocation and strategic missteps, leading to underperformance compared to tech stocks. Many other REITs, however, have been beaten down due to short-term supply headwinds and their treatment as bond proxies.

Seekingalpha | 1 year ago
2 REITs To Buy Before December 18th

2 REITs To Buy Before December 18th

The Fed is about to cut interest rates again. We think that this bodes well for REITs. Here are 2 REITs that we are buying ahead of December 18th.

Seekingalpha | 1 year ago
Realty Income: What Could Turn The Tide?

Realty Income: What Could Turn The Tide?

Realty Income offers stable income but lacks recent capital appreciation. Management should focus on share buybacks to drive price appreciation. Diversified portfolio with more than 15,000 properties, but stepping outside core competencies has led to underperformance compared to Agree Realty. Agree Realty's focused strategy on high-quality tenants and U.S.-based retail has resulted in superior returns and growth potential.

Seekingalpha | 1 year ago
Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC

Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC

This is the first breakthrough therapy designation granted to MRK's sacituzumab tirumotecan in the United States.

Zacks | 1 year ago
Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC

Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC

GILD and Germany-based Tubulis collaborate to discover and develop an antibody-drug conjugate against a solid tumor target.

Zacks | 1 year ago
Grab Magnificent Monthly Passive Income From 5 High-Yielding Quality Stocks

Grab Magnificent Monthly Passive Income From 5 High-Yielding Quality Stocks

Most dividend investors seek solid passive income streams from quality dividend stocks.

247wallst | 1 year ago
Loading...
Load More